Detalles de la búsqueda
1.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 129(23): 3735-3745, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658621
2.
Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options.
Br J Haematol
; 201(1): 15-24, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709623
3.
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Br J Haematol
; 201(6): 1169-1178, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949658
4.
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
Blood
; 137(4): 556-568, 2021 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33104215
5.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779595
6.
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 98(4): 580-587, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36626592
7.
Irradiation-free, T-cell replete haploidentical transplant for Fanconi anaemia, weighing the benefits.
Br J Haematol
; 199(5): 639-641, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36121005
8.
Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies.
Br J Haematol
; 197(1): 28-40, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671973
9.
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?
Br J Haematol
; 197(3): 326-338, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286719
10.
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 127(2): 209-218, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119152
11.
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Cancer
; 127(4): 609-618, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085090
12.
Taking a BiTE out of the CAR T space race.
Br J Haematol
; 195(5): 689-697, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34131894
13.
Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells.
Br J Haematol
; 195(5): 660-668, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036558
14.
Machine learning and artificial intelligence in haematology.
Br J Haematol
; 192(2): 239-250, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32602593
15.
The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T-cell therapy.
Br J Haematol
; 193(6): 1060-1075, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33928630
16.
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Br J Haematol
; 193(3): 592-601, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838047
17.
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia.
Haematologica
; 106(6): 1591-1598, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32354866
18.
Hematopoietic Cell Transplant Consideration for Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia Patients.
Biol Blood Marrow Transplant
; 26(1): e16-e20, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31445182
19.
FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 26(11): 2165-2173, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717436
20.
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 26(7): 1247-1256, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32165328